Cytek Biosciences Inc (CTKB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	22.96% 44.86	58.23	48.00	49.69	37.09
Cost Of Revenue	13.25% 21.85	25.18	20.82	21.53	16.05
Gross Profit	30.36% 23.01	33.05	27.18	28.16	21.04
Operating Expenses	1.69% 33.75	33.19	33.60	37.29	33.20
Interest Income/Expense	11.93% 0.441	0.394	0.595	0.409	0.673
Benefits Costs and Expenses	0.50% 53.85	54.12	52.19	56.29	46.13
Costs And Expenses	0.50% 53.85	54.12	52.19	56.29	46.13
Operating Income/Loss	7,735% -10.73	-0.137	-6.42	-9.127	-12.16
Nonoperating Income/Loss	59.02% 1.741	4.248	2.235	2.532	3.122
Income/Loss From Continuing Operations Before Tax	318.75% -8.993	4.111	-4.185	-6.595	-9.04
Income Tax Expense/Benefit	102.87% -2.824	-1.392	2.271	-2.207	-2.233
Income/Loss From Continuing Operations After Tax	212.10% -6.169	5.503	-6.456	-4.388	-6.807
Net Income/Loss	212.10% -6.169	5.503	-6.456	-4.388	-6.807
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	22,678% 130.92	-0.5799	136.17	135.92	135.49
Diluted Average Shares	22,678% 130.92	-0.5799	136.17	135.92	135.49
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

STE

$217.09

1.38%

ZBH

$113.02

0.43%

PHG

$25.95

0.43%

DXCM

$76.27

0.51%

GEHC

$82.72

1.17%

$69.89

3.14%